Transmission of antiretroviral-drug-resistant HIV-1 variants
- 1 August 1999
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 354 (9180), 729-733
- https://doi.org/10.1016/s0140-6736(98)12262-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Impact of drug resistance mutations on virologic response to salvage therapyAIDS, 1999
- Sexual Transmission of an HIV-1 Variant Resistant to Multiple Reverse-Transcriptase and Protease InhibitorsNew England Journal of Medicine, 1998
- Antiretroviral Drug Resistance Testing in Adults With HIV InfectionJAMA, 1998
- A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected PatientsJAMA, 1998
- Resistance and cross-resistance with saquinavir and other HIV protease inhibitorsAIDS, 1998
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Transmission of Human Immunodeficiency Virus Type 1 Resistant to Nevirapine and ZidovudineThe Journal of Infectious Diseases, 1997
- HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and TherapyScience, 1995
- HIV-1 Reverse Transcription A Termination Step at the Center of the GenomeJournal of Molecular Biology, 1994
- Symptomatic Primary Infection Due to Human Immunodeficiency Virus Type 1: Review of 31 CasesClinical Infectious Diseases, 1993